46 Xy Disorder Of Sex Development Induced By Maternal Exposure To Endocrine Disruptors C5679871 vs 4 Hydroxyphenylacetic Aciduria C1848680

Choose 46 Xy Disorder Of Sex Development Induced By Maternal Exposure To Endocrine Disruptors C5679871 when

• Atypical sex development in a 46,XY infant or child

  The reproductive phenotype and chromosomal context fit the left concept better.

  Moderate

• Documented or strongly suspected prenatal endocrine-disruptor exposure

  Exposure history is part of the proposed etiology, although individual causation is not proven.

  Low

• Need for multidisciplinary DSD evaluation

  Endocrine, genetic, and psychosocial assessment is more relevant than metabolic screening alone.

  Moderate

Choose 4 Hydroxyphenylacetic Aciduria C1848680 when

• Abnormal newborn or infant metabolic screening

  The right concept is typically identified through biochemical testing rather than genital findings.

  Moderate

• Elevated 4-hydroxyphenylacetic acid on urine testing

  This supports the named biochemical abnormality but does not by itself prove a specific diagnosis.

  Moderate

• Dietary management is being considered

  The source describes dietary modification and monitoring, pending clinician confirmation.

  Low

46 Xy Disorder Of Sex Development Induced By Maternal Exposure To Endocrine Disruptors C5679871

Outcome

Long-term outcome is variable and not established by the supplied data.

Factors

Degree of atypical development, associated findings, and access to specialist care may matter.

4 Hydroxyphenylacetic Aciduria C1848680

Outcome

Course may be manageable with monitoring, but outcome is not established here.

Factors

Confirmation of the biochemical abnormality, dietary needs, and associated metabolic disease may matter.